195 related articles for article (PubMed ID: 26137268)
1. The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.
Ogawa H; Nagano H; Konno M; Eguchi H; Koseki J; Kawamoto K; Nishida N; Colvin H; Tomokuni A; Tomimaru Y; Hama N; Wada H; Marubashi S; Kobayashi S; Mori M; Doki Y; Ishii H
Mol Clin Oncol; 2015 May; 3(3):563-571. PubMed ID: 26137268
[TBL] [Abstract][Full Text] [Related]
2. Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer.
Wang H; Peng R; Chen X; Jia R; Huang C; Huang Y; Xia L; Guo G
Oncol Lett; 2018 Apr; 15(4):5553-5560. PubMed ID: 29552193
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.
Lockney NA; Zhang M; Lu Y; Sopha SC; Washington MK; Merchant N; Zhao Z; Shyr Y; Chakravarthy AB; Xia F
J Gastrointest Cancer; 2015 Dec; 46(4):390-8. PubMed ID: 26385349
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome.
Mohammad GH; Olde Damink SW; Malago M; Dhar DK; Pereira SP
PLoS One; 2016; 11(3):e0151635. PubMed ID: 26989901
[TBL] [Abstract][Full Text] [Related]
5. Expression of
Ishfaq M; Bashir N; Riaz SK; Manzoor S; Khan JS; Bibi Y; Sami R; Aljahani AH; Alharthy SA; Shahid R
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328104
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.
Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H
BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
Wu J; Hu L; Chen M; Cao W; Chen H; He T
Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
[TBL] [Abstract][Full Text] [Related]
9. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
10. GLUT1 and PKM2 may be useful prognostic predictors in patients with non‑small cell lung cancer following curative R0 resection.
Ito R; Yashiro M; Tsukioka T; Izumi N; Komatsu H; Inoue H; Yamamoto Y; Nishiyama N
Oncol Lett; 2023 Mar; 25(3):129. PubMed ID: 36844619
[TBL] [Abstract][Full Text] [Related]
11. Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.
Hamabe A; Yamamoto H; Konno M; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Nishida N; Kawamoto K; Koseki J; Doki Y; Mori M; Ishii H
Cancer Sci; 2014 Sep; 105(9):1100-8. PubMed ID: 25060325
[TBL] [Abstract][Full Text] [Related]
12. Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis.
Huang C; Huang Z; Bai P; Luo G; Zhao X; Wang X
Onco Targets Ther; 2018; 11():2075-2082. PubMed ID: 29695915
[TBL] [Abstract][Full Text] [Related]
13. Targeting Pyruvate Kinase M2 and Hexokinase II, Pachymic Acid Impairs Glucose Metabolism and Induces Mitochondrial Apoptosis.
Miao G; Han J; Zhang J; Wu Y; Tong G
Biol Pharm Bull; 2019 Jan; 42(1):123-129. PubMed ID: 30381614
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
Zhu H; Luo H; Zhu X; Hu X; Zheng L; Zhu X
Oncotarget; 2017 Jan; 8(1):1628-1640. PubMed ID: 27911861
[TBL] [Abstract][Full Text] [Related]
15. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
[TBL] [Abstract][Full Text] [Related]
17.
Lai YJ; Chou YC; Lin YJ; Yu MH; Ou YC; Chu PW; Wu CC; Wang YC; Chao TK
Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31756939
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
Wu J; Hu L; Wu F; Zou L; He T
Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
